The U.S. Food and Drug Administration on Tuesday declined full approval for Intercept Pharmaceuticals' liver disease drug, ...
In a new study, researchers at McMaster University have identified a potential treatment for Sandhoff and Tay-Sachs ...
IQVIA reported annual sales for the twelve months ending September 2024 of $4.3 billion for the brand and generic market for this product. About Elite Pharmaceuticals, Inc.
PTC Therapeutics' gene therapy is already approved in the European Union, Great Britain, and Israel. The drugmaker will ...
Many seriously ill people die waiting for the FDA to approve drugs that regulators in other advanced countries have already ...
Azurity Pharma gets US FDA approval for Danziten tablets, the first and only nilotinib with no mealtime restrictions: Woburn, Massachusetts Saturday, November 16, 2024, 17:00 Hrs ...
Aucatzyl is the first CAR-T cell therapy approved by the FDA with no requirement for a risk evaluation mitigation strategy ...
Journey Medical's new rosacea treatment will rival industry giant Galderma's Oracea in the treatment of rosacea.
The US Food and Drug Administration announced a proposal to remove oral phenylephrine – a common ingredient in many popular ...
Kebilidi is the first approved gene therapy that can be directly administered to the brain. Its OK secures a priority review ...